Therapies
Thursday, August 7th, 2014
Neurolog: August 6, 2014 Objective: We sought to identify current US hospital practices for feeding tube placement in ischemic stroke. Methods: In a retrospective observational study, we examined the frequency of feeding tube placement among hospitals in the Nationwide Inpatient Sample with ≥30 adult ischemic stroke admissions annually with length of stay greater than 3 days. We examined […]
Therapies
Thursday, August 7th, 2014
STROKEAHA: August 5, 2014 Analysis of the National Institute of Neurological Disorders and Stroke Tissue-Type Plasminogen Activator Trials Background and Purpose—Several definitions have been proposed to distinguish clinically relevant from incidental cerebral hemorrhagic transformation after thrombolytic therapy for acute ischemic stroke. We investigated which definition best identifies cerebral hemorrhages that alter long-term functional outcome in the […]
Therapies
Thursday, August 7th, 2014
AHA: July 31, 2014 Background and Purpose—Whether intracerebral hemorrhage (ICH) survivors should restart antithrombotic drugs is unknown. We analyzed the frequency of restarting antithrombotic drugs in ICH survivors who had taken prophylactic antithrombotic drugs in atrial fibrillation or after thromboembolic disease in 5 cohorts and explored factors associated with doing so. Methods—We compared the characteristics […]
Guidelines, Therapies
Thursday, August 7th, 2014
CIRCULATIONAHA: 8/5/14 The American Heart Association/American College of Cardiology Prevention Guidelines A 58-year-old man, JB, schedules a visit with his primary care physician to explore what he could do to prevent a heart attack or stroke. He previously considered himself in good health and is not aware of any medical problems or symptoms. His visit is […]
Therapies
Thursday, August 7th, 2014
JAMA: July 28, 2014 Importance Intravenous thrombolysis remains the mainstay treatment for acute ischemic stroke. One of the most feared complications of the treatment is thrombolysis-related symptomatic intracerebral hemorrhage (sICH), which occurs in nearly 6% of patients and carries close to 50% mortality. The treatment options for sICH are based on small case series and expert opinion, and […]
Therapies
Thursday, August 7th, 2014
Wiley: 25 JUL 2014 Abstract Purpose To critically appraise the evidence on dabigatran etexilate, Pradaxa, as an alternative to warfarin for stroke prevention among patients with nonvalvular atrial fibrillation. This information can assist nurse practitioners in making informed treatment decisions. Data sources A review of the literature was conducted using CINAHL and PubMed databases. Reports […]
Therapies
Thursday, August 7th, 2014
STROKEAHA: July 1, 2014 Hypertension is the premier modifiable risk factor for stroke.1,2 Indeed, ≤50% of strokes may be attributable to hypertension, and the relationship of hypertension with stroke also comprises distinct independent links between both systolic and diastolic hypertension and the occurrence of both primary and recurrent strokes.3 Furthermore, the underlying pathophysiological rationale and clinical trial evidence […]
Therapies
Thursday, August 7th, 2014
STROKEAHA: June 19, 2014 After rehabilitation, most stroke survivors return to the community and continue with their daily lives, despite stroke-related functional, cognitive, and behavioral changes.1Caregivers are the primary support system for these survivors after discharge and an integral part of the healthcare team that contributes to survivors’ rehabilitation and recovery.2,3 However, caregiving is stressful, and caregivers […]
Therapies
Friday, July 25th, 2014
J NeuroIntervent Surg: 23 July 2014 Over the past decade there has been a growing use of intracranial stents for the treatment of both ischemic and hemorrhagic cerebrovascular disease, including stents to assist in the remodeling of the neck of aneurysms as well as the use of flow diverting devices for aneurysm treatment. With this increase […]
Therapies
Friday, July 25th, 2014
STROKEAHA: July 22, 2014 Background and Purpose—Intraventricular hemorrhage is associated with high mortality and poor functional outcome. The use of intraventricular fibrinolytic (IVF) therapy as an intervention in intraventricular hemorrhage is an evolving therapy with conflicting reports in the literature. The goal of this study is to investigate the impact of IVF on mortality, functional outcome, […]
